Dr. Shea Michael Eckardt, MD

Dr. Eckardt practices at Morton Plant Mease Hospital in Clearwater, Florida.

Dr. Eckardt's NPI, 1730363912, was assigned on December 23, 2007. Dr. Eckardt graduated from St. George's University School of Medicine in 2004. Dr. Eckardt holds Florida license ME 106174.

Dr. Eckardt's primary practice is Morton Plant Mease Hospital, at 430 Morton Plant St, Clearwater, FL 33756 in Pinellas County. The practice phone is (727) 462-7237.

Dr. Eckardt's primary practice is Morton Plant Mease Hospital in Clearwater, Florida. Dr. Eckardt is also affiliated with Morton Plant Hospital. The medical group on file is BayCare Medical Group. Dmand AI also links Dr. Eckardt to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eckardt practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Eckardt's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Eckardt is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Eckardt's licenses on file in 2 states: Florida and New York.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, lung disease: COPD, asthma or bronchitis, pleural effusion and pneumonia among the conditions Dr. Eckardt treats.

CMS data shows 1,807 Medicare services from Dr. Eckardt across 18 procedure codes in 2024, for 538 Medicare patients. Medicare paid $155,671 for them.

CMS counts 538 Medicare patients who saw Dr. Eckardt in 2024. The largest group is 75 to 84, with 247 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eckardt's median patient age at 73, with 57% women.

In 2024, Dr. Eckardt wrote 1,724 Medicare Part D claims for 268 patients. 41% of them were for generic drugs. CMS names the drug for 1,572 of them, across 34 drugs with 11 or more claims each, at $835,936 in total drug cost. In 2023, CMS named 1,402 claims across 31 drugs.

Dr. Eckardt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Eckardt in 2010. The most frequent topics are Biopsy, Needle and Tomography, X-Ray Computed. Dr. Eckardt's most frequent co-author is Ernest M. Scalzetti, MD.

CMS Open Payments shows 509 general payments to Dr. Eckardt from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. GlaxoSmithKline, LLC. paid the most, $1,572.

Dmand AI lists 1 award for Dr. Eckardt, most recently CMS Stage 1 EHR in 2013.

Dr. Eckardt graduated from St. George's University School of Medicine in 2004.

Dr. Eckardt is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.